Dr. Pashankar is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
LMP 2073
333 Cedar Street
New Haven, CT 06510Phone+1 203-785-4640Fax+1 203-737-2228
Education & Training
- University of Iowa Hospitals and ClinicsFellowship, Pediatric Hematology/Oncology, 2003 - 2004
- University of Iowa Hospitals and ClinicsResidency, Pediatrics, 2001 - 2003
- B.J. Medical College - University of PuneClass of 1988
Certifications & Licensure
- CT State Medical License 2004 - 2025
- IA State Medical License 2000 - 2005
- American Board of Pediatrics Pediatric Hematology-Oncology
Awards, Honors, & Recognition
- Howard A. Pearson Pediatric Faculty Teaching Award Yale University School of Medicine, 2012, 2015
- Pediatric Faculty Scholar Award Yale University School of Medicine, 2009
- Travel Award, Sickle Cell Vasculopathy Conference NIH, 2008
Publications & Presentations
PubMed
- Management of recurrent and persistent malignant ovarian germ cell tumors: a narrative review.Dimitrios Nasioudis, Farzana Dinesh Pashankar
International Journal of Gynecological Cancer. 2024-09-02 - 1 citationsNeuroblastoma, Version 2.2024, NCCN Clinical Practice Guidelines in Oncology.Rochelle Bagatell, Julie R Park, Sahaja Acharya, Jennifer Aldrink, Jenna Allison
Journal of the National Comprehensive Cancer Network. 2024-08-01 - 3 citationsConsensus and controversy in the management of paediatric and adult patients with ovarian immature teratoma: the Malignant Germ Cell International Consortium perspective.Farzana Pashankar, Matthew J Murray, Joanna Gell, Nicola MacDonald, Jonathan Shamash
Eclinicalmedicine. 2024-03-01
Journal Articles
- Is Adjuvant Chemotherapy indicated in Ovarian Immature Teratoma? A Combined Data Analysis from The Malignant Germ Cell Tumor International Collaborative (MaGIC)Pashankar FD, Juliet P. Hale, Ha Dang, Mark Krailo, William E. Brady, Carlos Rodriguez-Galindo, James C. Nicholson, Matthew J. Murray, Deborah F. Bilmire, Sara Stoneha..., Cancer, 1/20/2015
- The Role of Registries and Tumor Banking in Rare Pediatric TumorsFarzana Pashankar, Gianni Bisogno, Raul Ribeiro, Yoav Messinger, KrisAnn Schultz, Carlos Rodriguez-Galindo, Curr Pediatr Rep, 1/1/2015
- Pediatric and Adolescent Extracranial Germ Cell Tumors – The Road to CollaborationThomas A. Olson, Matthew J. Murray, Carlos Rodriguez-Galindo,James C. Nicholson, Deborah F. Billmire, Mark D. Krailo, Ha Dang, James F. Amatruda, Claire M.Thornton, G...., J Clin Oncol, 1/1/2015
- Join now to see all
Books/Book Chapters
Abstracts/Posters
- Orbital masses, two cases reports.Pashankar F, American Society of Pediatric Hematology Oncology Annual Meeting, 1/1/2014
- Development of a Multi-Disciplinary Inpatient Program for Children with Sickle Cell Disease Admitted for Vaso-Occulusive Crisis.Pashankar F, 6th Annual Sickle Cell Disease Research and Education Symposium, Hollywood, FL, 1/1/2013
- Longitudnal FU of elevated TR jet Velocity in Children with Sickle Cell DiseasePashankar F, American Society of Pediatric Hematology Oncology Annual Meeting, Miami, FL, 1/1/2013
- Join now to see all
Lectures
- Reduction in Hospital Days Using a Multidisciplinary Approach for Pediatric Patients with Sickle Cell Disease2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
- Heredity and Sickle Cell DiseaseBethany Community School - 1/1/2015
- Using Every Child Protocol as a Rare Tumor Registry1/1/2014
- Join now to see all
Press Mentions
- NCI Grants $1.8M for Cancer Genome Atlas Research, Sarah Cannon Names Navneet Majhail Physician-in-Chief of Blood Cancers, and MoreOctober 1st, 2021
- Yale Names Head of Pediatric OncologyJune 29th, 2021
- New Strategies for Treating Pediatric Sickle Cell DiseaseFebruary 4th, 2020
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: